Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Stroke showdown: drug plus procedure vs. procedure alone for basilar artery blockage

NCT ID NCT05631847

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 345 people with a severe stroke caused by a blockage in the basilar artery, a major blood vessel in the brain. It compared two treatments: giving a clot-busting drug followed by a procedure to remove the clot, versus doing the procedure alone. The goal was to see which approach helps more patients recover with little or no disability after 90 days.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

345 people

The number who actually took part.

Started

Apr 2023

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: 1. A clinical diagnosis of AIS. 2. Caused by BAO confirmed by CTA, MRA, or DSA. (BAO is defined as the absence of visualization of the basilar artery on CTA, MRA or DSA. Bilateral vertebral artery occlusions or occlusion of a unilateral vertebral artery that is the sole supplier of the basilar artery, even in the presence of patent basilar artery, will be considered de facto BAO.) 3. CT or MRI ruling out intracranial hemorrhage, 4. Eligible for IVT and EVT (within 4.5 hours of symptom onset). (Symptoms onset is defined as point in time the patient was last seen well \[at baseline\] if patients are unable to provide a reliable history or the point in time when symptoms have started if patients can provide a reliable history. Symptoms onset includes diplopia, midline ataxia, visual loss, sensory or motor deficits, and conscious disturbance. Isolated vertigo \[not accompanied by dysarthria, motor weakness, sensory symptoms, double vision, depressed level of consciousness\] is not considered onset of symptoms.) 5. NIHSS score ≥ 6. 6. Age ≥ 18 years. 7. Signed informed consent by the patient or legal representative. Exclusion criteria: 1. mRS score \> 2 before this stroke. 2. Any contraindication to IVT as per the 2019 AHA/ASA guidelines for early management of AIS: 1\) Blood pressure \> 185/110 mmHg and cannot be controlled by standard medication, 2) Blood glucose \< 50mg/dL (2.8 mmol/L) or \> 400mg/dL (22.2 mmol/L), 3) Had a cerebral infarction in the previous 6 weeks with residual neurological deficit or signs of recent infarction on neuroimaging, 4) Severe head trauma in the previous 3 months, 5) Major surgery or severe trauma in the previous 2 weeks, 6) Gastrointestinal or urinary bleeding in the previous 3 weeks, 7) previous intracranial hemorrhage, 8) Using anticoagulants and International normalized ratio (INR) \> 1.7, 9) Known platelet count \< 100 × 109/L, 10) treatment with direct thrombin or factor X inhibitors, 11) Heparin treatment in the previous 48 hours with the activated partial thromboplastin time (APTT) exceeding the upper limit of normal. (3) Pregnancy, breastfeeding, or intention to conceive during the study period. (4) Other conditions deemed unsuitable by the investigator.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute ischemic stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Affiliated Hospital of Chengdu Medical College

    Chengdu, Sichuan, China

  • Affiliated Hospital of North Sichuan Medical College

    Nanchong, Sichuan, China

  • Affiliated Hospital of Southwest Medical University

    Luzhou, Sichuan, China

  • Affiliated Traditional Chinese Medicine Hospital of Southwest Hospital Medical University

    Luzhou, Sichuan, China

  • Anyang People's Hospital

    Anyang, Henan, China

  • Banan Hospital Affiliated to Chongqing Medical University

    Chongqing, Chongqing Municipality, China

  • Bazhong Central Hospital

    Bazhong, Sichuan, China

  • Changde First People's Hospital

    Changde, Hunan, China

  • Chengdu Fifth People's Hospital

    Chengdu, Sichuan, China

  • Chengdu First People's Hospital

    Chengdu, Sichuan, China

  • Chengdu Second People's Hospital

    Chengdu, Sichuan, China

  • Chengdu Third People's Hospital

    Chengde, Sichuan, China

  • Chenzhou First People's Hospital

    Chenzhou, Hunan, China

  • Chongqing Sanbo Chang'an Hospital

    Chongqing, Chongqing Municipality, China

  • Chongqing University Affiliated S Central Hospital

    Chongqing, Chongqing Municipality, China

  • Chongqing University Medical University Affiliated Yongchuan Hospital

    Chongqing, Chongqing Municipality, China

  • Chongqing Yongchuan District People's Hospital

    Chongqing, Chongqing Municipality, China

  • Chongzhou People's Hospital

    Chengdu, Sichuan, China

  • Dayi County People's Hospital

    Chengdu, Sichuan, China

  • Deyang People's Hospital

    Deyang, Sichuan, China

  • Guang'an Central Hospital

    Guang’an, Sichuan, China

  • Guanghan People's Hospital

    Luocheng, Sichuan, China

  • Guangyuan Central Hospital

    Guangyuan, Sichuan, China

  • Guangyuan First People's Hospital

    Guangyuan, Sichuan, China

  • Hechuan District People's Hospital

    Chongqing, Chongqing Municipality, China

  • Heze Municipal Hospital

    Heze, Shandong, China

  • Huai'an First People's Hospital

    Huaian, Jiangsu, China

  • Jiaozuo Second People's Hospital

    Jiaozuo, Henan, China

  • Jilin University Sino Japanese Friendship Hospital

    Changchun, Jilin, China

  • Jingjiang People's Hospital

    Jingjiang, Jiangsu, China

  • Jinhua Central Hospital

    Jinhua, Zhejiang, China

  • Jintang County People's Hospital

    Jintang, Sichuan, China

  • Langzhong People's Hospital

    Nanchong, Sichuan, China

  • Leshan People's Hospital

    Leshan, Sichuan, China

  • Lezhi County People's Hospital

    Ziyang, Sichuan, 610000, China

  • Liangping District People's Hospital

    Chongqing, Chongqing Municipality, China

  • Liangshan Prefecture First People's Hospital

    Xichang, Sichuan, China

  • Liangshan Prefecture Second People's Hospital

    Xichang, Sichuan, 610000, China

  • Liaocheng Second People's Hospital

    Liaocheng, Shandong, China

  • Linyi Traditional Chinese Medicine Hospital

    Linyi, Shandong, China

  • Luoyang Central Hospital

    Luoyang, Henan, China

  • Maoming County Traditional Chinese Medicine Hospital

    Maoming, Guangdong, China

  • Meishan Cardiovascular and Cerebrovascular Disease Hospital

    Meishan, Sichuan, China

  • Meishan Second People's Hospital

    Meishan, Sichuan, China

  • Meishan Traditional Chinese Medicine Hospital

    Meishan, Sichuan, China

  • Mianyang 404 Hospital

    Mianyang, Sichuan, China

  • Mianyang Central Hospital

    Mianyang, Sichuan, China

  • Mianyang Third People's Hospital

    Mianyang, Sichuan, China

  • Nanchong Central Hospital

    Nanchong, Sichuan, China

  • Nanyang Central Hospital

    Nanyang, Henan, China

  • Nanyang Nanshi Hospital

    Nanyang, Henan, China

  • Neijiang Second People's Hospital

    Neijiang, Sichuan, China

  • Pangang Group General Hospital

    Panzhihua, Sichuan, China

  • Panzhihua Central Hospital

    Panzhihua, Sichuan, China

  • Pingchang County People's Hospital

    Pingchang, Sichuan, China

  • Puyang Oilfield General Hospital

    Puyang, Henan, China

  • Qiandongnan Miao and Dong Autonomous Prefecture People's Hospital

    Kaili, Guizhou, China

  • Qujing First People's Hospital

    Qujing, Yunnan, China

  • Rizhao Traditional Chinese Medicine Hospital

    Rizhao, Shandong, China

  • Shifang People's Hospital

    Fangting, Sichuan, China

  • Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital

    Chengdu, Sichuan, China

  • Sichuan Third People's Hospital

    Chengdu, Sichuan, 610054, China

  • Suining Central Hospital

    Suining, Sichuan, China

  • Suining First People's Hospital

    Suining, Sichuan, China

  • Taizhou First People's Hospital

    Taizhou, Zhejiang, China

  • Taizhou Hospital of Zhejiang Province

    Taizhou, Zhejiang, China

  • Taizhou People's Hospital

    Taizhou, Jiangsu, China

  • The Fifth People's Hospital Affiliated to Southern Medical University

    Guangzhou, Guangdong, China

  • The First Hospital of Jilin University

    Jilin City, Jilin, China

  • The First People's Hospital of Liangjiang New Area

    Chongqing, Chongqing Municipality, China

  • The First People's Hospital of Suqian City

    Suqian, Jiangsu, China

  • The Second Affiliated Hospital of Shandong First Medical University

    Taian, Shandong, China

  • Tieling Central Hospital

    Tieling, Liaoning, China

  • West China Hospital of Sichuan University

    Chengdu, Sichuan, 610054, China

  • Western Theater General Hospital

    Chengdu, Sichuan, China

  • Xiangtan Central Hospital

    Xiangtan, Hunan, China

  • Xiangyang Central Hospital

    Xiangyang, Hubei, China

  • Xinxiang Central Hospital

    Xinxiang, Henan, China

  • Xuzhou Medical University Affiliated Hospital

    Xuzhou, Jiangsu, China

  • Ya'an People's Hospital

    Ya'an, Sichuan, China

  • Yancheng First People's Hospital

    Yancheng, Jiangsu, China

  • Yibin First People's Hospital

    Yibin, Sichuan, China

  • Yibin Second People's Hospital

    Yibin, Sichuan, China

  • Yilong County People's Hospital

    Nanchong, Sichuan, China

  • Yingkou Central Hospital

    Yingkou, Liaoning, China

  • Yongkang First People's Hospital

    Guli, Zhejiang, China

  • Yuebei People's Hospital

    Shaoguan, Guangdong, China

  • Yulin First People's Hospital

    Yulin, Guangxi, China

  • Zhangzhou Hospital

    Zhangzhou, Fujian, China

  • Zhengzhou Central Hospital

    Zhengzhou, Henan, China

  • Zhoukou Central Hospital

    Zhoukou, Henan, China

  • Zhumadian Central Hospital

    Zhumadian, Henan, China

  • Zigong First People's Hospital

    Zigong, Sichuan, China

  • Zigong Fourth People's Hospital

    Zigong, Sichuan, China

  • Zigong Third People's Hospital

    Zigong, Sichuan, China

  • Ziyang First People's Hospital

    Ziyang, Sichuan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.